1. Executive Summary |
2. Global Breast Cancer Screening Market Introduction |
2.1. Global Breast Cancer Screening Market – Taxonomy |
2.2. Global Breast Cancer Screening Market –Definitions |
2.2.1. Component |
2.2.2. Technology |
2.2.3. Application |
2.2.4. End User |
2.2.5. By Region |
3. Global Breast Cancer Screening Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Breast Cancer Screening Market Dynamic Factors - Impact Analysis |
3.6. Global Breast Cancer Screening Market – Competition Landscape |
3.7. Epidemiology |
4. Global Breast Cancer Screening Market Analysis, 2017-2021 and Forecast, 2022-2028 |
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Breast Cancer Screening Market, By Component, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.1. Reagents and Kits |
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Instruments |
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Software and Services |
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6. Global Breast Cancer Screening Market, By Technology, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.1. Imaging |
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Biopsy |
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Genomic Tests |
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Blood Tests |
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Others |
6.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7. Global Breast Cancer Screening Market, By Application, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.1. Screening |
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Diagnostic and Predictive |
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Prognostic |
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Research |
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8. Global Breast Cancer Screening Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.1. Hospitals and Clinics |
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Diagnostic Centers |
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Academic and Research Institutes |
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Others |
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
9. Global Breast Cancer Screening Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
9.1. North America |
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia-Pacific |
9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Latin America |
9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Middle East and Africa |
9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
9.6. Global Breast Cancer Screening Market - Opportunity Analysis Index, By Component, By Technology, By Application, By End User, and Region, 2022-2028 |
10. North America Breast Cancer Screening Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
10.1. Component Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Reagents and Kits |
10.1.2. Instruments |
10.1.3. Software and Services |
10.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.2.1. Imaging |
10.2.2. Biopsy |
10.2.3. Genomic Tests |
10.2.4. Blood Tests |
10.2.5. Others |
10.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Screening |
10.3.2. Diagnostic and Predictive |
10.3.3. Prognostic |
10.3.4. Research |
10.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Hospitals and Clinics |
10.4.2. Diagnostic Centers |
10.4.3. Academic and Reaserach Institutes |
10.4.4. Others |
10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.5.1. USA |
10.5.2. Canada |
10.6. North America Breast Cancer Screening Market - Opportunity Analysis Index, By Component, By Technology, By Application, By End User, and Country, 2022-2028 |
10.7. North America Breast Cancer Screening Market Dynamics – Trends |
11. Europe Breast Cancer Screening Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
11.1. Component Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Reagents and Kits |
11.1.2. Instruments |
11.1.3. Software and Services |
11.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Imaging |
11.2.2. Biopsy |
11.2.3. Genomic Tests |
11.2.4. Blood Tests |
11.2.5. Others |
11.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Screening |
11.3.2. Diagnostic and Predictive |
11.3.3. Prognostic |
11.3.4. Research |
11.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.4.1. Hospitals and Clinics |
11.4.2. Diagnostic Centers |
11.4.3. Academic and Reaserach Institutes |
11.4.4. Others |
11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.5.1. Germany |
11.5.2. UK |
11.5.3. France |
11.5.4. Spain |
11.5.5. Italy |
11.5.6. Rest of Europe |
11.6. Europe Breast Cancer Screening Market - Opportunity Analysis Index, By Component, By Technology, By Application, By End User, and Country, 2022-2028 |
11.7. Europe Breast Cancer Screening Market Dynamics – Trends |
12. Asia-Pacific Breast Cancer Screening Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
12.1. Component Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Reagents and Kits |
12.1.2. Instruments |
12.1.3. Software and Services |
12.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.2.1. Imaging |
12.2.2. Biopsy |
12.2.3. Genomic Tests |
12.2.4. Blood Tests |
12.2.5. Others |
12.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Screening |
12.3.2. Diagnostic and Predictive |
12.3.3. Prognostic |
12.3.4. Research |
12.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Hospitals and Clinics |
12.4.2. Diagnostic Centers |
12.4.3. Academic and Reaserach Institutes |
12.4.4. Others |
12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.5.1. China |
12.5.2. India |
12.5.3. Japan |
12.5.4. ASEAN |
12.5.5. Australia & New Zealand |
12.5.6. Rest of Asia-Pacific |
12.6. Asia-Pacific Breast Cancer Screening Market - Opportunity Analysis Index, By Component, By Technology, By Application, By End User, and Country, 2022-2028 |
12.7. Asia-Pacific Breast Cancer Screening Market Dynamics – Trends |
13. Latin America Breast Cancer Screening Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
13.1. Component Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Reagents and Kits |
13.1.2. Instruments |
13.1.3. Software and Services |
13.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.2.1. Imaging |
13.2.2. Biopsy |
13.2.3. Genomic Tests |
13.2.4. Blood Tests |
13.2.5. Others |
13.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Screening |
13.3.2. Diagnostic and Predictive |
13.3.3. Prognostic |
13.3.4. Research |
13.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Hospitals and Clinics |
13.4.2. Diagnostic Centers |
13.4.3. Academic and Reaserach Institutes |
13.4.4. Others |
13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.5.1. Brazil |
13.5.2. Mexico |
13.5.3. Rest of Latin America |
13.6. Latin America Breast Cancer Screening Market - Opportunity Analysis Index, By Component, By Technology, By Application, By End User, and Country, 2022-2028 |
13.7. Latin America Breast Cancer Screening Market Dynamics – Trends |
14. Middle East and Africa Breast Cancer Screening Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
14.1. Component Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.1.1. Reagents and Kits |
14.1.2. Instruments |
14.1.3. Software and Services |
14.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.2.1. Imaging |
14.2.2. Biopsy |
14.2.3. Genomic Tests |
14.2.4. Blood Tests |
14.2.5. Others |
14.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.3.1. Screening |
14.3.2. Diagnostic and Predictive |
14.3.3. Prognostic |
14.3.4. Research |
14.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.4.1. Hospitals and Clinics |
14.4.2. Diagnostic Centers |
14.4.3. Academic and Reaserach Institutes |
14.4.4. Others |
14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
14.5.1. Gulf Cooperation Council (GCC) Countries |
14.5.2. South Africa |
14.5.3. Rest of MEA |
14.6. MEA Breast Cancer Screening Market - Opportunity Analysis Index, By Component, By Technology, By Application, By End User, and Country, 2022-2028 |
14.7. MEA Breast Cancer Screening Market Dynamics – Trends |
15. Competition Landscape |
15.1. Strategic Dashboard of Top Market Players |
15.2. Company Profiles (Introduction, Financial Analysis, Key Components, Key Developments, Strategies, and SWOT Analysis) |
15.2.1. General Electric Company |
15.2.2. Siemens Healthineers AG |
15.2.3. BD |
15.2.4. Danaher |
15.2.5. F. Hoffmann-La Roche Ltd. |
15.2.6. Hologic Inc. |
15.2.7. Koninklijke Philips N.V. |
15.2.8. Myriad Genetics |
15.2.9. Oncocyte Corporation |
15.2.10. QIAGEN |
15.2.11. Syantra, Inc. |
15.2.12. Thermo Fisher Scientific Inc. |
16. Research Methodology |
17. Key Assumptions and Acronyms |